Our trusted team of thought leaders provides the latest insights and perspectives on important health industry and management consulting trends and topics.
This structured approach guides Med Affairs leaders in executing micro-transformations to drive meaningful impact for your organization and patients.
Vynamic helped the client develop an innovation capability to run agile experiments and identify potential solutions.
Following an acquisition, a global biopharmaceutical company needed to consolidate disparate brands into a single portfolio.
In the midst of integrating one company from a prior deal, a mid-sized pharmaceutical organization made an additional acquisition.
Read how a European-based regional HR organization within a Global Pharmaceutical company asked Vynamic to assess the current state of Diversity.
A high-impact DEI strategy requires an intentional approach that aligns organizational leaders around a singular vision.
Navigating changes in structure and responsibilities can present operational and cultural challenges for a team.
Enhancing the performance of omnichannel activities is now a priority for many life sciences companies.
Medical affairs plays a critical role in key activities for pharmaceutical companies. This includes evidence generation, evidence dissemination.
A global pharmaceutical company based in Europe needed to ensure robust and consistent product launch execution by Medical Affairs teams.
A leading health system identified an urgent need to adapt to organizational challenges exacerbated by the COVID-19 pandemic.
Pricing transparency laws are an opportunity to meaningfully improve patient experience and innovative leaders in healthcare are using this.